Conditions

  In this week’s series of Homerun Slides, we continue with our update on the current state of type 2 therapy with Dr. Stanley Schwartz. Topics include: Potential mechanisms of reducing CV outcomes with DPP-IV inhibitors; exenatide and CV outcomes; and Incretins in Type 2 Patients….

Metformin plus Cycloset shows significant CVD risk reduction for type 2 diabetes patients in trial….

Body fat content more significant than absolute body far amount….

Researchers review potential new drug treatment options for type 2 diabetes patients….

Only 2-4 healthy messages per week can have a positive impact….

  In this week’s Homerun Slides, we continue our series from Dr. Stanley Schwartz, with a focus on some of the treatments drugs including metformin, pioglitazone, and the glp-1 agonists….

Anne Peters, MD, and Lori Laffel, MD, MPH, Editors Jane Lee Chiang, MD, Managing Editor Continuous Subcutaneous Insulin Infusion (CSII) PEDIATRICS David Maahs, MD, PhD, and H. Peter Chase, MD Standard of Care A consensus statement on the use of insulin pump therapy, CSII, in youth with type 1 diabetes (T1D) …

A potential new treatment option for T2 diabetes…. 

Increased vegetable protein consumption may lessen risks of gestational diabetes…. 

A new drug target for obesity and diabetes may be on the horizon….